Metastatic Pancreatic Cancer

View All

Pancreatic Cancer Therapeutics Market Outlook
Treatment to Clinical Development – A Bumpy Journey for Pancreatic Cancer

Treatment for pancreatic cancer patients is challenging and not well defined, especially for patients with disease progression or adverse events seen after initial treatment. Studies suggest that, after diagnosis, about 22% of pancreatic cancer patients, regardless of their clinical stage of cancer, receive no trea...

Find More

Metastatic Pancreatic Cancer market
Metastatic Pancreatic Cancer Market Size: Emerging therapies, Unmet needs and Forecast analysis

Pancreas is a gland which has two components exocrine component and endocrine component.  The exocrine component which is responsible for making proteins/ enzymes and releasing them into small intestines for easy digestion. On the other hand, the endocrine component of the pancreas is responsible for making ho...

Find More